Concentration of clarithromycin and 14-R-hydroxy-clarithromycin in plasma of patients with Mycobacterium avium complex infection, before and after the addition of rifampicin

F. Yamamoto, S. Harada, T. Mitsuyama, Y. Harada, Y. Kitahara, M. Yoshida, Yoichi Nakanishi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Clarithromycin (CAM) and rifampicin (RFP) have both been recognized to be effective antibiotic agents against Mycobacterium avium complex (MAC) infection. Rifamycin derivatives including RFP and rifabutin modulate the CAM metabolism by inducing the hepatic cytochrome p-450 3A4. To clarify the effect of RFP on the CAM metabolism, we measured the plasma concentration of CAM and 14-R-hydroxyclarithromycin (M-5), the major metabolite of CAM, in 9 patients suffering from MAC infection before and after the addition of RFP. After the addition of RFP, the mean plasma concentration of CAM significantly decreased, while that of M-5 did not. In addition, the amount of CAM+M-5 concentration also significantly decreased. As M-5 is less effective against MAC infection than CAM, more attention should thus be paid to the plasma CAM concentration in patients administered CAM and RFP concomitantly.

Original languageEnglish
Pages (from-to)124-133
Number of pages10
JournalJapanese Journal of Antibiotics
Volume57
Issue number1
Publication statusPublished - Feb 1 2004
Externally publishedYes

Fingerprint

Mycobacterium avium Complex
Clarithromycin
Rifampin
Infection
14-R-hydroxy-clarithromycin
Rifabutin
Cytochromes
Anti-Bacterial Agents

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Concentration of clarithromycin and 14-R-hydroxy-clarithromycin in plasma of patients with Mycobacterium avium complex infection, before and after the addition of rifampicin. / Yamamoto, F.; Harada, S.; Mitsuyama, T.; Harada, Y.; Kitahara, Y.; Yoshida, M.; Nakanishi, Yoichi.

In: Japanese Journal of Antibiotics, Vol. 57, No. 1, 01.02.2004, p. 124-133.

Research output: Contribution to journalArticle

Yamamoto, F. ; Harada, S. ; Mitsuyama, T. ; Harada, Y. ; Kitahara, Y. ; Yoshida, M. ; Nakanishi, Yoichi. / Concentration of clarithromycin and 14-R-hydroxy-clarithromycin in plasma of patients with Mycobacterium avium complex infection, before and after the addition of rifampicin. In: Japanese Journal of Antibiotics. 2004 ; Vol. 57, No. 1. pp. 124-133.
@article{34da5e0ddd6b4f67ae977dbdcce8a8f1,
title = "Concentration of clarithromycin and 14-R-hydroxy-clarithromycin in plasma of patients with Mycobacterium avium complex infection, before and after the addition of rifampicin",
abstract = "Clarithromycin (CAM) and rifampicin (RFP) have both been recognized to be effective antibiotic agents against Mycobacterium avium complex (MAC) infection. Rifamycin derivatives including RFP and rifabutin modulate the CAM metabolism by inducing the hepatic cytochrome p-450 3A4. To clarify the effect of RFP on the CAM metabolism, we measured the plasma concentration of CAM and 14-R-hydroxyclarithromycin (M-5), the major metabolite of CAM, in 9 patients suffering from MAC infection before and after the addition of RFP. After the addition of RFP, the mean plasma concentration of CAM significantly decreased, while that of M-5 did not. In addition, the amount of CAM+M-5 concentration also significantly decreased. As M-5 is less effective against MAC infection than CAM, more attention should thus be paid to the plasma CAM concentration in patients administered CAM and RFP concomitantly.",
author = "F. Yamamoto and S. Harada and T. Mitsuyama and Y. Harada and Y. Kitahara and M. Yoshida and Yoichi Nakanishi",
year = "2004",
month = "2",
day = "1",
language = "English",
volume = "57",
pages = "124--133",
journal = "The Journal of antibiotics. Ser. B",
issn = "0368-2781",
publisher = "Japan Antibiotics Research Association",
number = "1",

}

TY - JOUR

T1 - Concentration of clarithromycin and 14-R-hydroxy-clarithromycin in plasma of patients with Mycobacterium avium complex infection, before and after the addition of rifampicin

AU - Yamamoto, F.

AU - Harada, S.

AU - Mitsuyama, T.

AU - Harada, Y.

AU - Kitahara, Y.

AU - Yoshida, M.

AU - Nakanishi, Yoichi

PY - 2004/2/1

Y1 - 2004/2/1

N2 - Clarithromycin (CAM) and rifampicin (RFP) have both been recognized to be effective antibiotic agents against Mycobacterium avium complex (MAC) infection. Rifamycin derivatives including RFP and rifabutin modulate the CAM metabolism by inducing the hepatic cytochrome p-450 3A4. To clarify the effect of RFP on the CAM metabolism, we measured the plasma concentration of CAM and 14-R-hydroxyclarithromycin (M-5), the major metabolite of CAM, in 9 patients suffering from MAC infection before and after the addition of RFP. After the addition of RFP, the mean plasma concentration of CAM significantly decreased, while that of M-5 did not. In addition, the amount of CAM+M-5 concentration also significantly decreased. As M-5 is less effective against MAC infection than CAM, more attention should thus be paid to the plasma CAM concentration in patients administered CAM and RFP concomitantly.

AB - Clarithromycin (CAM) and rifampicin (RFP) have both been recognized to be effective antibiotic agents against Mycobacterium avium complex (MAC) infection. Rifamycin derivatives including RFP and rifabutin modulate the CAM metabolism by inducing the hepatic cytochrome p-450 3A4. To clarify the effect of RFP on the CAM metabolism, we measured the plasma concentration of CAM and 14-R-hydroxyclarithromycin (M-5), the major metabolite of CAM, in 9 patients suffering from MAC infection before and after the addition of RFP. After the addition of RFP, the mean plasma concentration of CAM significantly decreased, while that of M-5 did not. In addition, the amount of CAM+M-5 concentration also significantly decreased. As M-5 is less effective against MAC infection than CAM, more attention should thus be paid to the plasma CAM concentration in patients administered CAM and RFP concomitantly.

UR - http://www.scopus.com/inward/record.url?scp=1842615046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842615046&partnerID=8YFLogxK

M3 - Article

VL - 57

SP - 124

EP - 133

JO - The Journal of antibiotics. Ser. B

JF - The Journal of antibiotics. Ser. B

SN - 0368-2781

IS - 1

ER -